quinonyl-mdp-66 has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, I; Souma, H; Tanio, Y; Tokushima, Y; Yamamura, Y | 1 |
| Azuma, I; Igari, Y; Ogawa, Y; Ukei, S; Yamamura, Y | 1 |
2 other study(ies) available for quinonyl-mdp-66 and Experimental Hepatoma
| Article | Year |
|---|---|
Regression of line-10 hepatocarcinoma with synthetic quinonyl muramyl dipeptide in strain-2 guinea pigs.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antineoplastic Agents; Cell Line; Drug Evaluation, Preclinical; Guinea Pigs; Liver Neoplasms, Experimental; Squalene | 1983 |
Antitumor activity on line 10 hepatoma in strain 2 guinea pigs and pharmaceutical properties of quinonyl-MDP preparations.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry; Emulsions; Female; Guinea Pigs; Liver Neoplasms, Experimental; Lymph Nodes; Male; Neoplasm Transplantation; Time Factors | 1986 |